Press Release

View all news

Incyte to Present at Upcoming Investor Conferences

November 17, 2022 at 8:00 AM EST

WILMINGTON, Del.--(BUSINESS WIRE)--Nov. 17, 2022-- Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November and December:

  • Evercore ISI 5th Annual HealthCONx Conference (Virtual) on Tuesday, November 29, 2022 at 12:35 pm (EST)
  • Bank of America Securities 2022 Biotech SMID Cap Conference on Wednesday, December 7, 2022 at 8:35 am (EST) in Boston

The presentations will be webcast live and can be accessed at and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.

Catalina Loveman
+1 302 498 6171

Christine Chiou
+1 302 274 4773

Source: Incyte